New Drugs and Novel Targets for Treatment of Invasive Fungal Infections in Patients with Cancer
Open Access
- 1 April 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 5 (2) , 120-135
- https://doi.org/10.1634/theoncologist.5-2-120
Abstract
Invasive fungal infections have emerged as important causes of morbidity and mortality in profoundly immunocompromised patients with cancer. Current treatment strategies for these infections are limited by antifungal resistance, toxicity, drug interactions, and expense. In order to overcome these limitations, new antifungal compounds are being developed, which may improve our therapeutic armamentarium for prevention and treatment of invasive mycoses in high-risk patitnts with neoplastic diseases.Keywords
This publication has 128 references indexed in Scilit:
- In vitro activity of voriconazole against selected fungiMedical Mycology, 2008
- Pradimicin therapy of disseminated Candida tropicalis infection in the mouseMedical Mycology, 2008
- Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungiMedical Mycology, 1998
- Activity of MK-0991 (l-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.Diagnostic Microbiology and Infectious Disease, 1998
- Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- The in-vitro activity of an antifungal antibiotic benanomicin A in comparison with amphotericin BJournal of Antimicrobial Chemotherapy, 1996
- Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Impact of the changing epidemiology of fungal infections in the 1990sEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Plasma itraconazole concentrations in neutropenic patients after repeated high-dose treatmentEuropean Journal Of Cancer, 1992
- Synergistic action of nikkomycin X/Z with azole antifungals on Candida albicansJournal of General Microbiology, 1991